Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 6, 2026, 4:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Stuttering, Adult Clear all

Conditions: Stuttering
Interventions: pagoclone, placebo; Drug · Other
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 321 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Stuttering, Adult
Interventions: Lumateperone (ITI-007), Placebo Tablet or Capsule; Drug
Lead sponsor: CSTrials Inc.; Network
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Costa Mesa, California

Conditions: Childhood-Onset Fluency Disorder (Stuttering)
Interventions: Ecopipam, Placebo; Drug
Lead sponsor: Emalex Biosciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 9
States / cities: Riverside, California • Santa Ana, California • Jacksonville, Florida + 6 more

Conditions: Stuttering, Developmental
Interventions: Anodal tDCS, Fluency training, Sham tDCS; Device · Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Stuttering, Adult, Childhood-onset Fluency Disorder, Speech Disorders, Language Disorders, Communication Disorder
Interventions: Ecopipam 50mg, Ecopipam 100mg; Drug
Lead sponsor: Gerald Maguire, MD; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Riverside, California

Conditions: Stuttering, Adult
Interventions: Altered Auditory Feedback; Device
Lead sponsor: Massachusetts Institute of Technology; Other
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Stuttering
Interventions: Asenapine; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Orange, California

Conditions: Stuttering, Adult
Interventions: Threat-related stimulus exposure; Behavioral
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Stuttering, Adult
Interventions: Aripiprazole 10 MG, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stuttering, Stuttering, Adult, Stuttering, Childhood, Stuttering, Developmental
Interventions: The Blank Center CARE Model(TM) for Individuals who Stutter; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 2 Years to 85 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2035
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Stuttering, Fluency Disorder
Interventions: High - Definition Transcranial Direct Current Stimulation; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Stutter, Stuttering, Adult, Stuttering, Stuttering, Developmental
Interventions: Speech Production During functional magnetic resonance imaging (MRI); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Stuttering, Stuttering, Childhood, Stuttering, Adult
Interventions: Speech and non-speech tasks; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 6 Years to 65 Years
Enrollment: 145 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Ann Arbor, Michigan • East Lansing, Michigan

Conditions: Stuttering, Adult
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Stuttering, Adult, Stuttering, Childhood, Stuttering, Developmental
Interventions: transcranial alternating current stimulation (tACS); Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan